跳至主要内容
临床试验/NCT02927808
NCT02927808已完成不适用

Motivational Interviewing to Support LDL-C Therapeutic Goals and Lipid-Lowering Therapy Compliance in Patients With Acute Coronary Syndromes: a Prospective Randomized Clinical Study

AHEPA University Hospital2 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2016年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
360
试验地点
2
主要终点
Achievement of low-density lipoprotein cholesterol therapeutic goal, as specified by current practice guidelines (LDL-C <70 mg/dL or >50% reduction from baseline LDL-C)

研究概览

简要总结

This study will investigate the impact of motivational interviewing in achieving low-density lipoprotein cholesterol therapeutic targets in patients with acute coronary syndromes.

详细描述

To determine whether a strategy of enhanced information about the risks of high plasma low-density lipoprotein cholesterol (LDL-C) and the importance of lipid-lowering medication together with close follow-up and motivational interviewing is superior than usual care in achieving LDL-C therapeutic targets, as set by current practice guidelines (LDL-C <70 mg/dL or >50% reduction from baseline LDL-C) in patients with acute coronary syndromes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject hospitalized for acute coronary syndrome (STEMI, NTEMI or unstable angina)
  • Subject currently on lipid-lowering therapy or prescribed lipid-lowering therapy at hospital discharge (statins and/or other agents)
  • Subject who is 18 years or older
  • Subject or legally authorized representative who is willing and capable of providing informed consent, participating in all associated study activities

排除标准

  • Subject unable to communicate via telephone for study interviewing
  • Subject with contraindication to statin therapy
  • Subject with any medical disorder that would interfere with completion or evaluation of clinical study results

结局指标

主要结局

Achievement of low-density lipoprotein cholesterol therapeutic goal, as specified by current practice guidelines (LDL-C <70 mg/dL or >50% reduction from baseline LDL-C)

时间窗: 12 months after discharge from hospital

次要结局

  • Overall adherence to lipid-lowering regimen, reported as both a continuous and a binary outcome, by using the 4-item Morisky Medication-Taking Adherence Scale(12 months after discharge from hospital)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Leonidas Lillis

MD, Clinical Research Associate

AHEPA University Hospital

研究点 (2)

Loading locations...

相似试验